eli lilly compound tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Eli Lilly Launches Self-Pay Vials
Description
Results from Phase 3 trials have put a new drug called Retatrutide (sometimes called Reta) back in the news again.
May assist in maintaining strength and endurance
Much of the refractory pain and suffering from these conditions might be attributable to obesity, so active questions will be raised about how GLP-1 agonists can influence the diseases we treat.
With rising interest in gut health and hormone balance, products likeSupergut GLP-1 Boosterhave gained significant attention
Tirzepatide passes into breast milk in animal studies, making breastfeeding during treatment a decision requiring medical guidance
This week, Phispers has news on antibiotics and cancer therapies
